Jieqiang Zhou,
Department:
Pharmacotherapy & Translational Research
Business Phone:
(352) 870-8682
Business Email:
zhou.jieqiang@ufl.edu
Publications
Academic Articles
2024
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation.
Antimicrobial agents and chemotherapy.
68(3)
[DOI] 10.1128/aac.01399-23.
[PMID] 38329330.
2024
Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics.
Antimicrobial agents and chemotherapy.
68(2)
[DOI] 10.1128/aac.01393-23.
[PMID] 38169309.
2022
Why Molnupiravir Fails in Hospitalized Patients.
mBio.
13(6)
[DOI] 10.1128/mbio.02916-22.
[PMID] 36374076.
2021
Combating Multidrug-Resistant Bacteria by Integrating a Novel Target Site Penetration and Receptor Binding Assay Platform Into Translational Modeling.
Clinical pharmacology and therapeutics.
109(4):1000-1020
[DOI] 10.1002/cpt.2205.
[PMID] 33576025.
2021
Combination Regimens of Favipiravir Plus Interferon Alpha Inhibit Chikungunya Virus Replication in Clinically Relevant Human Cell Lines.
Microorganisms.
9(2)
[DOI] 10.3390/microorganisms9020307.
[PMID] 33540830.
2020
First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus.
Antimicrobial agents and chemotherapy.
65(1)
[DOI] 10.1128/AAC.01956-20.
[PMID] 33106266.
2020
Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five β-Lactams Simultaneously in Carbapenem-Resistant Klebsiella pneumoniae and Enterobacter cloacae.
mBio.
11(1)
[DOI] 10.1128/mBio.03189-19.
[PMID] 32047131.
Contact Details
Phones:
- Business:
- (352) 870-8682
Emails:
- Business:
- zhou.jieqiang@ufl.edu
Addresses:
- Business Mailing:
-
6550 SANGER RD
ORLANDO FL 32827 - Business Street:
-
6550 SANGER RD OFC 473
ORLANDO FL 32827